iSeed in $4.8m round for MySugr

Following completion of the deal, the business will look to increase its international footprint, with most of its customers currently based in the US.

Roche Ventures, the venture arm of Swiss pharmaceutical and medical technology business Roche, also took part in the round alongside existing investor XLHealth.

The transaction marks iSeed's first investment outside of the US and China.

Company
Founded in 2012 and headquartered in Vienna, MySugr provides digital services for people with diabetes. The business develops the MySugr Logbook app for diabetes management, which operates on a freemium ad-supported model, and runs the MySugr Academy education platform.

People
Adam Lin is a general partner at iSeed. Simon Meier is an investment director at Roche Ventures. Frank Westermann is CEO of MySugr.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• DACH
• Technology
• Austria